Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge fund Grifphon’s founder Yusaf Jawed pleads guilty to Ponzi scheme

Wednesday, April 17, 2013

From Komfie Manalo, Opalesque Asia – Portland, Oregon-based hedge fund manager Yusaf Jawed pleaded guilty to 17 counts of mail and wire fraud in a Ponzi scheme that spans several states including Oregon and Washington, according to media reports.

A report by the Seattle Times said that the 44-year-old ex-stockbroker is facing up to six and a half years imprisonment in his sentencing scheduled on June 21.

Assistant U.S. Attorney Allan Garten said that Jawed had accepted the court’s order for him to surrender the $6.4m in ill-gotten gains and pay back his investors.

But attorney Michael Esler, who is representing one of Jawed’s victims, said none of the investors are expecting to see the money.

Court records showed that Jawed ran the Ponzi scheme for more than 10 years. However, the crimes to which he pleaded guilty came from investors he took money from between February 2008 and September 2009.

In September 2012, the SEC filed fraud charges against Jawed, alleging that he had used false marketing materials that boasted double-digit returns to lure people to invest their money into several hedge funds that he managed through at least two companies he controlled: Grifphon Asset Management LLC and Grifphon Holdings LLC.

The SEC’s complaint further alleg......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its